1997
DOI: 10.1111/j.1528-1157.1997.tb01095.x
|View full text |Cite
|
Sign up to set email alerts
|

Epilepsy in Peroxisomal Diseases

Abstract: Summary:Purpose: To clarify the electroclinical manifestation of epileptic seizures and the evolution of epilepsy in patients with peroxisomal diseases.Methods: Retrospective review of the medical records and EEGs of 14 patients with peroxisomal diseases: seven with Zellweger syndrome (ZS), two with neonatal adrenoleukodystrophy (NALD), two with acyl-CoA oxidase deficiency (AOXD), two with bifunctional enzyme deficiency (BFED), and one with rhizomelic chondrodysplasia punctata (RCDP). The diagnoses were made b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 39 publications
(19 citation statements)
references
References 18 publications
1
18
0
Order By: Relevance
“…Our results on the occurrence of seizures are in agreement with earlier studies [16]. However, previous studies have not considered the impact of the severity of biochemical defects and specific mutations in relation to epilepsy [22,23]. We found that epilepsy occurs frequently in RCDP patients irrespective of genotype or phenotype.…”
Section: Discussionsupporting
confidence: 92%
“…Our results on the occurrence of seizures are in agreement with earlier studies [16]. However, previous studies have not considered the impact of the severity of biochemical defects and specific mutations in relation to epilepsy [22,23]. We found that epilepsy occurs frequently in RCDP patients irrespective of genotype or phenotype.…”
Section: Discussionsupporting
confidence: 92%
“…We obtained literature cases from reports published in English (n = 62). [Lightwood, 1931; Bateman, 1936; Maitland, 1939; Hilliard, 1943; Lund, 1943; Coughlin et al, 1950; Ford et al, 1951; Scott, 1952; Briggs et al, 1953; Fraser and Scriver, 1954; Yakovac, 1954; Cohen et al, 1956; Sheach and Middlemiss, 1956; Armaly, 1957; Phillips, 1957; Brogdon and Crow, 1958; Mosekilde, 1958; van Balen and Santens, 1968; Spranger et al, 1971; Mason and Kozlowski, 1973; Levine et al, 1974; Gilbert et al, 1976; Heselson et al, 1978; Kretzer et al, 1981; Saul and Stevenson, 1982; Connor et al, 1985; Poulos et al, 1988, 1991; Eustis et al, 1990; Gray et al, 1990, 1992; Wardinsky et al, 1990; Castillo‐Taucher et al, 1991; Lenti et al, 1991; Williams et al, 1991; Suzuki et al, 1993; Gendall et al, 1994; Agamanolis and Novak, 1995; Takahashi et al, 1997; Hertzberg et al, 1999; Powers et al, 1999; Steinberg et al, 1999; Khanna et al, 2001]. We excluded certain instances in which review suggested that the proffered diagnosis was implausible or in which documentation was insufficient to confirm that the child did, indeed, have RCP, or in those few instances where the proband likely did not have classical RCP Type I.…”
Section: Methodsmentioning
confidence: 99%
“…Seizures have been observed in the neonatal period in nearly all severely affected PBD-ZSD patients [70], and have been reported in 23% of less severe patients [18]. EEGs can determine the frequency and duration of seizures and should be performed whenever changes in seizure activity are suspected.…”
Section: Management and Treatment Guidelinesmentioning
confidence: 99%